Lumefantrine is a long-acting antimalarial agent typically combined with artemether in artemisinin-based combination therapies (ACTs). It disrupts the parasite's ability to detoxify heme, leading to its death. Lumefantrine enhances the effectiveness of artemether by maintaining prolonged antimalarial activity and preventing recurrence.